MindwaysCT, a leading medical device applications provider, has signed an exclusive distributorship agreement with Mindways Australia to deploy QCT Pro™ software throughout Australia, including remote areas with little or no access to effective bone density screening. QCT PRO™ software produces bone densitometry reports for the spine and hip, and can be combined with other standard CT imaging procedures.
An estimated 2 million Australians are living with osteoporosis and many more go undiagnosed until they suffer a fracture; with hip fractures being the most prevalent. QCT technology produces DXA-equivalent reports of the hip, and results can be integrated into other treatment tools such as FRAX. QCT spine measurements are made in the trabecular bone - where the first signs of decreasing in bone mass can be identified, making it possible to detect and treat osteoporotic conditions sooner than other screening technology.
MindwaysCT Australia Managing Director, Jeff Wheeler said, "After using QCT PRO™ for over 10 years, I am truly excited to be providing local support to the Australian market and expanding the role of QCT in early detection of osteoporosis and fracture prevention. QCT has some clear advantages for bone density measurement in being able to reliably measure BMD in patients even when they have arthritis, aortic calcification, scoliosis or they are obese".
In addition, hospitals and clinics in rural areas and with limited budgets can implement QCT software and conduct BMD screening on their existing CT scanners. Because QCT scans take less than five minutes of CT scanner time, radiology departments can conduct BMD tests and improve equipment utilization without overburdening them.
MindwaysCT Head of Business Development Alan Brett said, 'We are very pleased to offer an alternative to DXA in a region in desperate need of affordable and accessible BMD screening. I'm confident that our technology will be well received, particularly in remote areas where existing equipment can be used and both spine and hip reports can be produced from a low-dose abdominal CT scan with radiation doses comparable to a mammogram.'
Mindways CT QCT Pro bone densitometry systems are TGA registered and qualify for a rebate via Medicare. The system can be used with any DICOM-capable CT scanner.
For more information about MindwaysCT Australia or QCT Pro™ software visit www.mindwaysaustralia.com.au or call 1800 739 780.
About MindwaysCT Software, Inc.
MindwaysCT produces Quantitative CT (QCT) bone densitometry products for spine and hip bone density measurements. Established in 1997, MindwaysCT has been a constant innovator in the field of CT bone densitometry, introducing the world's first commercial 3D QCT spine systems and CTXA hip systems. MindwaysCT premier product, QCT Pro™ uses CT images to derive DXA-like hip BMD measurements and volumetric spine BMD measurements. QCT Pro™ hip BMD measurements are interpreted in the same manner as DXA, while spine measurements provide exceptional sensitivity to short-term bone density change. QCT Pro™ is fast, easy, covered by insurance, and provides the same clinical utility as DXA at a fraction of its cost. MindwaysCT has offices in Austin, Texas and Kiel, Germany.
For more information on Mindways Software and QCT Pro™, please visit www.qct.com.
Media Contact:
Alan Brett, VP Business Development
+1 512 912 0871
alan@qct.com